title: A favorable risk-benefit analysis of high dose thyroid for treatment of bipolar disorders with regard to osteoporosis.
abstract: High dose thyroid hormone has been in use since the 1930s for the treatment of affective disorders. Despite numerous papers showing benefit, the lack of negative trials and its inclusion in multiple treatment guidelines, high dose thyroid has yet to find wide spread use. The major objection to the use of high dose thyroid is the myth that it causes osteoporosis. This paper reviews the literature surrounding the use of high dose thyroid, both in endocrinology and in psychiatry. High dose thyroid does not appear to be a significant risk factor for osteoporosis while other widely employed psychiatric medications do pose a risk. Psychiatrists are uniquely qualified to do the risk-benefit analyses of high dose thyroid for the treatment of the bipolar I, bipolar II and bipolar NOS. Other specialties do not have the requisite knowledge of the risks of alterative medications or of the mortality and morbidity of the bipolar disorders to do a full risk benefit analysis.
authors: Psychiatry and Behavioral Sciences George Washington University, The Depression & Bipolar Clinic of Colorado, USA. Electronic address: TamKelly@comcast.net.
authors: Tammas
authors: T
authors: Kelly
mesh_terms: D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced*; D012306:Risk; D013963:Thyroid Hormones / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D013963:Thyroid Hormones
keywords: Bipolar I; Bipolar II; High dose thyroid; Osteoporosis; Risk benefit; Treatment